Syrris to Host Technical Seminars in India for R&D Chemists
News May 10, 2010
Syrris, has announced that, due to significant interest in India for its range of automated batch reactor and flow chemistry products, it will be hosting two applications-focused seminars.
Taking place on Monday 10th May (Hyderabad) and Thursday 13th May (Ahmedabad), each seminar will include introductory discussions and workshops.
Syrris’ Global Head of Sales, Dr. Omar Jina, will introduce seminars on calorimetry, sonocrystallization and flow chemistry. He said: “This is an extremely exciting time for Syrris Ltd India. With sales increasing at a rapid pace, we wanted to provide users with the opportunity to actively participate in workshops and discussions, ensuring that they are fully aware of the capabilities of each system.”
Since incorporating its Indian subsidiary in 2009, Syrris has experienced outstanding levels of success within the Indian market. Syrris’ flow chemistry products include FRX, a modular flow chemistry system and Africa, a fully-automated microreactor flow system.
The batch reactor products include the Atlas automated synthesis system, which provides complete control over one, or parallel, reactions up to 5 litres in vials, flasks or jacketed reactors. With its ability to provide temperature control and accurate results, the Atlas Calorimetry System has been particularly successful.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018